Document Detail


Effects of dietary cholesterol on plasma lipoproteins and their subclasses in IDDM patients.
MedLine Citation:
PMID:  9498653     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
To compare the effects of dietary cholesterol supplementation in insulin-dependent diabetic (IDDM) patients and normal subjects, 10 male IDDM patients in good glycaemic control (HbA1c 7.3+/-0.9%) (mean+/-SD) and normal plasma lipid levels, and 11 control male subjects of similar age, body mass index and lipid plasma levels underwent a double blind, cross-over, sequential study. Cholesterol supplementation of 800 mg/day or placebo were given for consecutive periods of 3 weeks. The concentration of plasma total cholesterol increased significantly with the dietary cholesterol supplementation compared to placebo in IDDM patients by 6% (p < 0.05) and in control subjects by 9% (p < 0.05). No changes were observed in the concentration of plasma triglycerides in either group. The LDL cholesterol level increased by 12% (p < 0.01) in patients and by 7% (p < 0.05) in control subjects. In patients plasma HDL cholesterol concentration remained the same, while in control subjects it tended to increase after cholesterol supplementation (from 1.14+/-0.26 to 1.23+/-0.27 mmol/l, p = 0.06). During the cholesterol intake period the mean concentration of LDL1, LDL2 and LDL3 subclasses in patients showed a significant increase by 21.0 (p < 0.05), 20.4 (p < 0.001) and 11.1% (p < 0.05), respectively, resulting in an 18.0% increase in mean total LDL mass (p < 0.001) without major changes in LDL composition. In the control subjects the changes in the concentrations of LDL subclasses during cholesterol intake were less and not significant. In the IDDM patients the cholesterol intake did not affect the concentration or composition of HDL subclasses or total HDL mass. In contrast, in control subjects cholesterol intake increased the mean concentration of HDL2a by 12.2.% (p < 0.05) and this increase was significantly different if compared to changes obtained in the patients. In conclusion, compared to normal subjects, in IDDM patients, dietary cholesterol intake increased the LDL particle mass significantly and had no positive effect on HDL.
Authors:
G Romano; M K Tilly-Kiesi; L Patti; M R Taskinen; D Pacioni; M Cassader; G Riccardi; A A Rivellese
Related Documents :
12521083 - Cholesterol lipoproteins, triglycerides, rural-urban differences and prevalence of dysl...
1466313 - Hypertriglyceridemia: risks and perspectives.
9437203 - Association of apo e polymorphism with plasma lipid levels in a multiethnic elderly pop...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Diabetologia     Volume:  41     ISSN:  0012-186X     ISO Abbreviation:  Diabetologia     Publication Date:  1998 Feb 
Date Detail:
Created Date:  1998-04-01     Completed Date:  1998-04-01     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0006777     Medline TA:  Diabetologia     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  193-200     Citation Subset:  IM    
Affiliation:
Department of Clinical and Experimental Medicine, Federico II University Medical School, Naples, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Cholesterol / blood
Cholesterol, Dietary / administration & dosage*
Cross-Over Studies
Diabetes Mellitus, Type 1 / blood*
Double-Blind Method
Humans
Lipoproteins / blood*
Lipoproteins, HDL / blood
Lipoproteins, LDL / blood
Lipoproteins, VLDL / blood
Male
Middle Aged
Chemical
Reg. No./Substance:
0/Cholesterol, Dietary; 0/Lipoproteins; 0/Lipoproteins, HDL; 0/Lipoproteins, LDL; 0/Lipoproteins, VLDL; 57-88-5/Cholesterol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Increased expression of selectins in kidneys of patients with diabetic nephropathy.
Next Document:  Enhanced erythrocyte Na+/H+ exchange predicts diabetic nephropathy in patients with IDDM.